Parnax Lab

Parnax Lab Net Margin

The Net Profit Margin of Parnax Lab (506128.BO) as of Nov 18, 2026 is 6.14 %. In the previous year, Net Profit Margin was 5.09 % — a change of 20.50% (higher).

Net Margin

6.14 %

YoY

20.50%

Last updated:

Net Profit Margin of Parnax Lab is 2025 6.14 % . Net Profit Margin of Parnax Lab was 2024 5.09 % . It decreases by 20.50% higher compared to the previous year.

For Parnax Lab, the net margin of 6.1% is up versus -0.4% a few years ago.

The Parnax Lab Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
1.00 INR
Jan 1, 2019
3.03 INR
Jan 1, 2020
-3.06 INR
Jan 1, 2021
-0.40 INR
Jan 1, 2022
5.06 INR
Jan 1, 2023
5.14 INR
Jan 1, 2024
5.09 INR
Jan 1, 2025
6.14 INR
The Parnax Lab Net Margin history
YEARNet MarginYoY
6.14 %+20.50%
5.09 %-0.97%
5.14 %+1.70%
5.06 %-1,351.01%
-0.40 %-86.78%
-3.06 %-200.82%
3.03 %+203.57%
1.00 %-73.60%
3.78 %+7.42%
3.52 %-14.77%
4.13 %+13.67%
3.64 %+11,770.81%
0.03 %-201.81%
-0.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Net Profit Margin of Parnax Lab is 6.14 % in 2025.

Net Profit Margin of Parnax Lab changed from 5.09 % to 6.14 %, representing a 20.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Parnax Lab with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Parnax Lab

All Key Metrics — Parnax Lab